NASDAQ: PFSA#5 smallestDigital health / biosensorsUnited States
Profusa, Inc.
$0.61845.01%USD · Nasdaq, delayed
Key statistics
Market cap$374.5K
Volume282,563
52-week high$1,726
52-week low$0.5984
From 52-week high-99.96%
Shares (implied)605,647
1% stake costs$3.7K
Listing config4bWZb…fiSce ↗
About Profusa
Berkeley company developing injectable, tissue-integrated biosensors: the Lumee Oxygen Platform (offered in the EU) and a months-long Lumee glucose monitor in R&D. Listed through its merger with NorthView Acquisition in July 2025.
Why it’s listed
More than a decade of implantable-sensor R&D, valued at about $0.37M on roughly 606k shares. A hard-tech platform this small needs a patient owner more than it needs another note.
Main risk
Funded by a run of convertible notes from August to October 2026, with $0.7M cash at June 30. It reverse-split 1-for-25 in July and 1-for-4 in August, and sought authority for up to 1-for-12 more.
The bid
LIVERaised
…
SOL
Stake funded
0%
- 1% stake$3.7KTop-holder list on most micro-caps
- 5% stake$18.7KSchedule 13D/13G beneficial-owner filing
- 10% stake$37.5KSection 16 insider status
- 50.1% stake$187.6KMajority control of the vote
Costs at the last price, before market impact.